The Drift-Reduction for Improved FFR Using Fiberoptic Technology (DRIFT) Study

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 19, 2018

Primary Completion Date

May 13, 2019

Study Completion Date

May 13, 2019

Conditions
Left Anterior Descending Coronary Artery Stenosis
Interventions
DEVICE

OpSens Medical OptoWire

"The OptoWire is FDA approved to measure pressure in coronary vessels during diagnostic angiography and coronary interventions.~The OptoWire Deux pressure wire (OpSens Medical, Quebec, Canada) is a novel technology utilizing optical coherence technology to enhance FFR assessment of the coronaries."

PROCEDURE

FFR

A guide wire-based procedure that can accurately measure blood pressure and flow through a specific part of the coronary artery. FFR is done through a standard diagnostic catheter at the time of a coronary angiogram (a.k.a. cardiac catheterization).

Trial Locations (2)

10032

New York Presbyterian Hospital/Columbia University Medical Center, New York

11576

St. Francis Hospital, Roslyn

All Listed Sponsors
lead

Columbia University

OTHER

NCT03848650 - The Drift-Reduction for Improved FFR Using Fiberoptic Technology (DRIFT) Study | Biotech Hunter | Biotech Hunter